These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24676404)

  • 21. N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection.
    Li Y; Rey-Cuille MA; Hu SL
    AIDS Res Hum Retroviruses; 2001 Nov; 17(16):1473-9. PubMed ID: 11709091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique profile of predominant CCR5-tropic in CRF07_BC HIV-1 infections and discovery of an unusual CXCR4-tropic strain.
    Hu X; Feng Y; Li K; Yu Y; Rashid A; Xing H; Ruan Y; Lu L; Wei M; Shao Y
    Front Immunol; 2022; 13():911806. PubMed ID: 36211390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07_BC strains circulating in the Xinjiang Province of China.
    Ma L; Guo Y; Yuan L; Huang Y; Sun J; Qu S; Yu X; Meng Z; He X; Jiang S; Shao Y
    Retrovirology; 2009 May; 6():45. PubMed ID: 19442296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies.
    Singh A; Collman RG
    J Virol; 2000 Nov; 74(21):10229-35. PubMed ID: 11024154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
    Huang W; Eshleman SH; Toma J; Fransen S; Stawiski E; Paxinos EE; Whitcomb JM; Young AM; Donnell D; Mmiro F; Musoke P; Guay LA; Jackson JB; Parkin NT; Petropoulos CJ
    J Virol; 2007 Aug; 81(15):7885-93. PubMed ID: 17507467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicted co-receptor tropism and sequence characteristics of China HIV-1 V3 loops: implications for the future usage of CCR5 antagonists and AIDS vaccine development.
    Zhang C; Xu S; Wei J; Guo H
    Int J Infect Dis; 2009 Sep; 13(5):e212-6. PubMed ID: 19217335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.
    Fernàndez G; Llano A; Esgleas M; Clotet B; Esté JA; Martínez MA
    J Gen Virol; 2006 May; 87(Pt 5):1285-1294. PubMed ID: 16603531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis for coreceptor selectivity by the HIV type 1 V3 loop.
    Cardozo T; Kimura T; Philpott S; Weiser B; Burger H; Zolla-Pazner S
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):415-26. PubMed ID: 17411375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.
    Lin NH; Becerril C; Giguel F; Novitsky V; Moyo S; Makhema J; Essex M; Lockman S; Kuritzkes DR; Sagar M
    Virology; 2012 Nov; 433(2):296-307. PubMed ID: 22954962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A virus-envelope paired competitive assay to study entry efficiency of human immunodeficiency virus type 1 in vitro.
    Schwalbe B; Hauser H; Schreiber M
    J Virol Methods; 2014 Sep; 205():91-8. PubMed ID: 24859049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
    Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
    J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.
    Sato H; Kato K; Takebe Y
    Virology; 1999 May; 257(2):491-501. PubMed ID: 10329559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.
    Pollakis G; Abebe A; Kliphuis A; Chalaby MI; Bakker M; Mengistu Y; Brouwer M; Goudsmit J; Schuitemaker H; Paxton WA
    J Virol; 2004 Mar; 78(6):2841-52. PubMed ID: 14990703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2.
    Xiang SH; Pacheco B; Bowder D; Yuan W; Sodroski J
    Virology; 2013 Mar; 438(1):5-13. PubMed ID: 23369572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
    Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
    Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4.
    Esté JA; Cabrera C; Blanco J; Gutierrez A; Bridger G; Henson G; Clotet B; Schols D; De Clercq E
    J Virol; 1999 Jul; 73(7):5577-85. PubMed ID: 10364306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.
    Schwalbe B; Schreiber M
    PLoS One; 2015; 10(3):e0119879. PubMed ID: 25785610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.